Jane Street
TARO

Jane Street’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Jane Street’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-3,400
Closed -$495K – 4673
2016
Q2 		$495K Buy
+3,400
New +$482K ﹤0.01% 2773

Other funds holding TARO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jane Street's TARO Position: Q3 2021 in Review

Jane Street sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q3 2021, closing a stake of 3,547 shares — an estimated $255K sold.

Jane Street first reported a position in TARO in Q1 2014 and held it in 13 quarters. The position peaked at $1.39M in Q3 2014. 71 funds tracked by Wall St. Rank hold TARO as of Q3 2021.

  • Jane Street reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q3 2021 after selling out during the quarter.
  • Jane Street sold 3,547 Taro Pharmaceutical Industries Ltd. shares in Q3 2021, an estimated $255K.
  • Jane Street first reported a position in Taro Pharmaceutical Industries Ltd. in Q1 2014 and held it in 13 quarters.
  • Jane Street's Taro Pharmaceutical Industries Ltd. position peaked at $1.39M in Q3 2014.
  • 71 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q3 2021.

Based on Jane Street's 13F filing for Q3 2021, filed 16 Nov 2021.